Longer term outcomes with pembrolizumab plus axitinib combination for advanced kidney cancer
This Practice Update interview with Dr Monty Pal from City [...]
HIF-2α inhibitor belzutifan to be fast-tracked for approval for VHL kidney cancer
Kidney cancers frequently have mutations in a gene called the [...]
Nivolumab/cabozantinib combination recommended for EMA approval for first-line kidney cancer
The Committee for Medicinal Products for Human Use (CHMP) of [...]
